Compare, Analyse Dr. Reddys with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. REDDYS LAB vs MYLAN (US) - Comparison Results

DR. REDDYS LAB     Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the pharmaceutical value chain - basic research, finished dosages, generics, bulk actives, and biotechnology. The company's business is mainly organized into Global g... More

MYLAN (US)
   Change

Mylan is one of the worlds leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industrys broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 DR. REDDYS LAB   MYLAN
EQUITY SHARE DATA
    DR. REDDYS LAB
Mar-20
MYLAN
Dec-18
DR. REDDYS LAB/
MYLAN
5-Yr Chart
Click to enlarge
High Rs3,3633,447-   
Low Rs2,3521,897-   
Sales per share (Unadj.) Rs1,054.21,586.0-  
Earnings per share (Unadj.) Rs121.943.1-  
Cash flow per share (Unadj.) Rs190.2340.0-  
Dividends per share (Unadj.) Rs25.000-  
Dividend yield (eoy) %0.90-  
Book value per share (Unadj.) Rs938.71,715.7-  
Shares outstanding (eoy) m166.17514.50-   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.71.7 160.9%   
Avg P/E ratio x23.462.0 37.8%  
P/CF ratio (eoy) x15.07.9 191.2%  
Price / Book Value ratio x3.01.6 195.5%  
Dividend payout %20.50-   
Avg Mkt Cap Rs m474,8311,374,707 34.5%   
No. of employees `00021.735.0 61.9%   
Total wages/salary Rs m33,8020-   
Avg. sales/employee Rs Th8,091.023,314.0 34.7%   
Avg. wages/employee Rs Th1,561.30-   
Avg. net profit/employee Rs Th935.8633.1 147.8%   
INCOME DATA
Net Sales Rs m175,170815,988 21.5%  
Other income Rs m6,2060-   
Total revenues Rs m181,376815,988 22.2%   
Gross profit Rs m24,421211,148 11.6%  
Depreciation Rs m11,348152,785 7.4%   
Interest Rs m98339,246 2.5%   
Profit before tax Rs m18,29619,116 95.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m5610-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1,403-3,041 46.1%   
Profit after tax Rs m20,26022,157 91.4%  
Gross profit margin %13.925.9 53.9%  
Effective tax rate %-7.7-15.9 48.2%   
Net profit margin %11.62.7 425.9%  
BALANCE SHEET DATA
Current assets Rs m125,991455,647 27.7%   
Current liabilities Rs m72,141332,217 21.7%   
Net working cap to sales %30.715.1 203.2%  
Current ratio x1.71.4 127.3%  
Inventory Days Days7384 87.4%  
Debtors Days Days10593 112.3%  
Net fixed assets Rs m83,854158,288 53.0%   
Share capital Rs m831434 191.3%   
"Free" reserves Rs m155,1570-   
Net worth Rs m155,988882,750 17.7%   
Long term debt Rs m1,304952,771 0.1%   
Total assets Rs m232,2532,367,879 9.8%  
Interest coverage x19.61.5 1,318.8%   
Debt to equity ratio x01.1 0.8%  
Sales to assets ratio x0.80.3 218.9%   
Return on assets %9.12.6 352.7%  
Return on equity %13.02.5 517.4%  
Return on capital %12.63.2 396.7%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m44,5770-   
CASH FLOW
From Operations Rs m29,841169,562 17.6%  
From Investments Rs m-4,923-87,645 5.6%  
From Financial Activity Rs m-25,159-78,992 31.9%  
Net Cashflow Rs m-2661,405 -18.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 72.41 Rs / USD

Compare DR. REDDYS LAB With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare DR. REDDYS LAB With: DIVIS LABORATORIES  ALEMBIC  UNICHEM LAB  CIPLA  GSK PHARMA  



Today's Market

Sensex Ends 257 Points Higher, Coal India and UPL Among Top Gainers(Closing)

Indian share markets continued their positive trend during closing hours today and ended their day on a firm note.

Related Views On News

Most Popular

Intraday Trading for a Living (Fast Profits Daily)

Feb 15, 2021

In this video, I'll cover your queries on intraday trading and also share my view on how to decide stop losses and target prices.

Penny Stock Master Series: The Quest for 10X Profits in 10 Years (Profit Hunter)

Feb 12, 2021

This is first of the three part master series. In these editorials, I'll show you how to earn 10X returns from a penny stock portfolio over 10 years.

Top 5 Stocks Mutual Funds Bought and Sold in January 2021 (Sector Info)

Feb 16, 2021

A look at what India's top equity mutual funds bought and sold in January 2021.

I Would Recommend this Small-cap Stock Over Tesla (Profit Hunter)

Feb 16, 2021

Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Access Now: Eight Steps to Your Eight Figure Fortune
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

DR. REDDYS LAB SHARE PRICE


Feb 25, 2021 (Close)

TRACK DR. REDDYS LAB

  • Track your investment in DR. REDDYS LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. REDDYS LAB

DR. REDDYS LAB 8-QTR ANALYSIS

COMPARE DR. REDDYS LAB WITH

FEATURED VIDEOS

How Long Before a Big Stock Market Crash

I Believe the Investment of the Year Will Be...

Nasdaq & Nifty Could Reverse

Don't Fall for the 'Best Sector of 2021' Story

More Featured Videos

MARKET STATS